These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 28775202)

  • 1. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
    Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
    Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
    Vrachimis A; Stegger L; Wenning C; Noto B; Burg MC; Konnert JR; Allkemper T; Heindel W; Riemann B; Schäfers M; Weckesser M
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1765-72. PubMed ID: 27059853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
    Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
    World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
    Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
    Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
    J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
    Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Somatostatin Receptor/
    Metser U; Nunez JE; Chan D; Kulanthaivelu R; Murad V; Santiago AT; Singh S
    J Nucl Med; 2024 Oct; 65(10):1591-1596. PubMed ID: 39266292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of [
    Jha A; Patel M; Ling A; Shah R; Chen CC; Millo C; Nazari MA; Sinaii N; Charles K; Kuo MJM; Prodanov T; Saboury B; Talvacchio S; Derkyi A; Del Rivero J; O'Sullivan Coyne G; Chen AP; Nilubol N; Herscovitch P; Lin FI; Taieb D; Civelek AC; Carrasquillo JA; Pacak K
    Eur Radiol; 2024 Oct; 34(10):6488-6498. PubMed ID: 38625612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
    Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of
    Liu Q; Zang J; Yang Y; Ling Q; Wu H; Wang P; Lu L; Zhu Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4386-4395. PubMed ID: 34146130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.